These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21896477)

  • 21. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ; Stawikowska R; Fields GB
    Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple-helical peptide analysis of collagenolytic protease activity.
    Lauer-Fields JL; Fields GB
    Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate conformation modulates aggrecanase (ADAMTS-4) affinity and sequence specificity. Suggestion of a common topological specificity for functionally diverse proteases.
    Lauer-Fields JL; Minond D; Sritharan T; Kashiwagi M; Nagase H; Fields GB
    J Biol Chem; 2007 Jan; 282(1):142-50. PubMed ID: 17095512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of helical cleavages in type II collagen generated by matrixins.
    Vankemmelbeke M; Dekeyser PM; Hollander AP; Buttle DJ; Demeester J
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):633-40. PubMed ID: 9480869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinase interactions with collagen and elastin.
    Van Doren SR
    Matrix Biol; 2015; 44-46():224-31. PubMed ID: 25599938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting MMP P
    Tokmina-Roszyk M; Fields GB
    J Biol Chem; 2018 Oct; 293(43):16661-16676. PubMed ID: 30185620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.
    Aimes RT; Quigley JP
    J Biol Chem; 1995 Mar; 270(11):5872-6. PubMed ID: 7890717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterotrimeric collagen peptides as fluorogenic collagenase substrates: synthesis, conformational properties, and enzymatic digestion.
    Müller JC; Ottl J; Moroder L
    Biochemistry; 2000 May; 39(17):5111-6. PubMed ID: 10819978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
    Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
    Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different collagenase gene products have different roles in degradation of type I collagen.
    Krane SM; Byrne MH; Lemaître V; Henriet P; Jeffrey JJ; Witter JP; Liu X; Wu H; Jaenisch R; Eeckhout Y
    J Biol Chem; 1996 Nov; 271(45):28509-15. PubMed ID: 8910479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.
    Lauer-Fields JL; Kele P; Sui G; Nagase H; Leblanc RM; Fields GB
    Anal Biochem; 2003 Oct; 321(1):105-15. PubMed ID: 12963061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite.
    Arnold LH; Butt LE; Prior SH; Read CM; Fields GB; Pickford AR
    J Biol Chem; 2011 Dec; 286(52):45073-82. PubMed ID: 22030392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity.
    Lauer-Fields JL; Chalmers MJ; Busby SA; Minond D; Griffin PR; Fields GB
    J Biol Chem; 2009 Sep; 284(36):24017-24. PubMed ID: 19574232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases.
    Kridel SJ; Sawai H; Ratnikov BI; Chen EI; Li W; Godzik A; Strongin AY; Smith JW
    J Biol Chem; 2002 Jun; 277(26):23788-93. PubMed ID: 11959855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New strategies for targeting matrix metalloproteinases.
    Fields GB
    Matrix Biol; 2015; 44-46():239-46. PubMed ID: 25595836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
    Nagase H; Fields CG; Fields GB
    J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.
    Mitchell PG; Magna HA; Reeves LM; Lopresti-Morrow LL; Yocum SA; Rosner PJ; Geoghegan KF; Hambor JE
    J Clin Invest; 1996 Feb; 97(3):761-8. PubMed ID: 8609233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining the Substrate Specificity of Matrix Metalloproteases using Fluorogenic Peptide Substrates.
    Stawikowski MJ; Knapinska AM; Fields GB
    Methods Mol Biol; 2017; 1579():137-183. PubMed ID: 28299736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
    Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
    J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases and collagen catabolism.
    Lauer-Fields JL; Juska D; Fields GB
    Biopolymers; 2002; 66(1):19-32. PubMed ID: 12228918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.